Dual blockade of endothelin and angiotensin II type 1 receptors could be an effective novel approach for the treatment of IgAN

○Hajime Nagasawa

2:00 PM - 2:12 PM

[28HS1-pm01] Dual blockade of endothelin and angiotensin II type 1 receptors could be an effective novel approach for the treatment of IgAN

○Hajime Nagasawa^1,2, Seiji Ueda¹, Hitoshi Suzuki^1,3, Celia Jenkinson⁴, Tomoyuki Otsuka¹, Teruyuki Okuma¹, Yusuke Fukao¹, Maiko Nakayama¹, Kai Liu⁴, Radko Komers⁴, Yusuke Suzuki¹ (1. Department of Nephrology, Juntendo University Faculty of Medicine, 2. Department of Nephrology, Juntendo University Shizuoka Hospital, 3. Department of Nephrology, Juntendo University Urayasu Hospital, 4. Travere Therapeutics, Inc)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[28HS1-pm] Pharmacotherapies (Basics) 2

[28HS1-pm01] Dual blockade of endothelin and angiotensin II type 1 receptors could be an effective novel approach for the treatment of IgAN

Password